SUPPORT HOTLINE (888) 901-2226
Donate Now

BCAN Updates

Bladder Cancer Awareness Month Kick Off!

Tuesday, May 01, 2018 The Bladder Cancer Advocacy Network Kicks-Off Bladder Cancer Awareness Month with “Shine a Light” Campaign The Bladder Cancer Advocacy Network is increasing awareness through walks, community activities and media attention around one of the most silent illnesses – bladder cancer BCAN CONTACT:           Stephanie Chisolm, PhD |

Read More

Photocure Announces FDA Approval of New Drug Application for Blue Light Cystoscopy with Cysview®

February 16, 2018– Today Photocure ASA announced the FDA approval of new indications for Blue Light Cystoscopy (BLC™) with Cysview®.  This supplemental new drug application (sNDA) will include Flexible Cystoscopes, which are used in the ongoing surveillance of bladder cancer patients bladder cancer. It is the only combination of drug

Read More

Announcing the Official Journal of BCAN!

    IOS Press, an international scientific, technical and medical publisher, and BCAN are pleased to announce that the journal Bladder Cancer is now our official journal!   As the result of this new partnership, Bladder Cancer and BCAN will combine resources to support a readily accessible information platform to

Read More

Announcing BCAN 2018 Young Investigator Awards!

The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2018 Young Investigator Awards (YIA), to support the development of outstanding early career research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer. In addition, for the first time,

Read More

Research Announcement | Accelerating Innovation in Military Medicine (AIMM) Funding Opportunity for Fiscal Year 2017 (FY17)

Defense Health Program, US Army Medical Research and Materiel Command (USAMRMC) The FY17 AIMM Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on in November 2017. This program supports highly creative and conceptually innovative high-risk research with the potential to accelerate critical

Read More